Navigation Links
QC 463 EQUIL® Plus with Glucose and Lactate Control

ProductsQC 463 EQUIL® Plus with Glucose and Lactate Control
Company RNA Medical
Item QC 463 EQUIL® Plus with Glucose and Lactate Control
Features 
  • Gold Standard procedure for blood gas analyzer accuracy
  • For use with the RNA Medical EQUILibrator® Tonometer
  • Stable up to 1 hour in capped syringe
  • Performs like human blood
  • Available in single or multi-level boxes
  • Peer comparison with optional on-line data submission
Description QC 463 is a quality control material that, once tonometered, is used for monitoring the performance of blood gas, electrolyte, metabolite, and CO-Oximeter instrumentation. It provides a practical alternative to the use of human blood in tonometry. QC 463 is available in three (3) levels for monitoring analyzer performance at varying points within the clinical range.
Info RNA Medical
Customer Service: (800) 533-6162
Web site: http://www.rnamedical.com/

Related medicine products :

1. Glucose (Hexokinase)
2. Glucose (Oxidase)
3. Glucose Color Reagent
4. Glucose Color Liquidplus Reagent
5. Glucose UV Reagent
6. Glucose UV Liquidplus
7. Glucose Hexokinase Reagent Set
8. Glucose Hexokinase Liquid
9. Glucose (Liquid) Reagent
10. Glucose Oxidase Reagent Set (Phenol Free)
11. CGMS System Gold Continuous Glucose Monitoring
...ectronic medical record software that allows medic...al record software and streamline the diagnostic a...cords software allows physicians to manage their p...tment scheduling, office visits, labs, health main...
AllMeds was the first specialty-specific Electronic Medical Record for Neurosurgery. Instead of trying to force a general-purpose EMR into your practice, AllMeds starts with clinical content from Neu
AllMeds was the first specialty-specific Electronic Medical Record for Orthopaedics. Instead of trying to force a general-purpose EMR into your practice, AllMeds starts with clinical content from Ort
... about 40% of the ophthalmic community. For that r...cal Shop can be used as a stand alone program or i.... Inventory is automatically updated from the nati...onnected to the EMR module would automatically pop...
Medicine Products:
(Date:12/2/2008)...more than two glasses a day linked to atrial fibr...2 (HealthDay News) -- A healthy middle-aged woman ... her risk of the abnormal heartbeat called atrial ...uding Dr. Christine M. Albert, a professor of medi...the large-scale Women,s Health study, looking for ...
(Date:12/2/2008)... The Health Story Project was...ject formerly known as “Clinical Document Ar...DT). CDA4CDT will continue as the label for the te...mitted to Health Level Seven (HL7) for ballot. The...ness Wire EON) December 2, 2008 -- "Our grou...
(Date:12/2/2008)...N ARBOR, Mich.---Older people tend to feel about 1...That is one of the findings of a study forthcoming...ience . The researchers analyzed the responses of ...d in the Berlin Aging Study, tracking how their pe...ing changed over a six-year period. , "People ge...
(Date:12/2/2008)...his release is available in French . , Deep v...ts in the lower limbs, is the third-most common va... and stroke, and is a frequent complication in hos...ondition that can lead to rapid death from pulmona...rious health concern that the U.S. Surgeon General...
Breaking Medicine News(10 mins):Health News:Light Drinking Poses No Heart Risk for Women 2Health News: "The Health Story Project" Adopted as New Brand by CDA4CDT : New Brand Underscores Comprehensive Electronic Health Records 2Health News: "The Health Story Project" Adopted as New Brand by CDA4CDT : New Brand Underscores Comprehensive Electronic Health Records 3Health News: "The Health Story Project" Adopted as New Brand by CDA4CDT : New Brand Underscores Comprehensive Electronic Health Records 4Health News: "The Health Story Project" Adopted as New Brand by CDA4CDT : New Brand Underscores Comprehensive Electronic Health Records 5Health News:Old as you want to be: Study finds most seniors feel younger 2Health News:Thrombosis patients face greater risks than previously believed 2
...e field of cancer and our improved understanding o...east cancer, an effective strategy to treat the di...nt additions to a large family known as the metall... down tissues and have therefore been linked with ...
...vices (HHS) plans to stock vaccines and anti-viral... criticism for the past some days by Infectious Di... say that the stocks are not enough and HHS should...ocks in order to effectively prevent flu pandemic....
...en who had day labor got longer pain relief than w...r pain medicine. This could be due to the impact o...e the effectiveness of spinal-epidural pain medica...time of administration of the medication is regard...
...iller which was found to cause the death of Robert...arma the manufacturers of Vioxx were asked by the ...// to Mrs. Ernst. Over 5 years, about 20 million p...elling the drug in September 2004, after a clinica...
Other Medicine News:Health News:Breast Cancer Advance 2Health News:Health and Human Services stockpiles 20 million bird flu Vaccines 2Health News:Timing Of Women's Labor May Determine Effectiveness Of Pain Medication 2
(Date:12/2/2008)...tCall/ -- Micromet, Inc. (Nasdaq: MITI ), a biop...y antibodies for the treatment of cancer, inflamma... it has entered into an agreement expanding its Co...sbridge Capital Limited, a private investment grou...has committed to provide up to $75 million of capi...
(Date:12/1/2008)...eGen has announced that an oral,presentation of ...clinical,trial of TG101348 in myeloproliferative ...merican Society of Hematology (ASH) Meeting. , ..., Title: A Phase I Study of TG10... JAK2-Selective Inhibitor, in Patients with, ...
(Date:12/1/2008)... a two-way switch that, if turned off, causes lymp... they lose their identity and become more like blo...c. 1 Scientists at St.... that a certain differentiated cell type is so rea...stant expression of a gene called Prox1 to dissu...
(Date:12/1/2008)...ay, December 9 at 11:00 am ET to Discuss Phase 2 S...ISCO, Calif., Dec. 1 S...biopharmaceutical company focused on the developme...ics, today announced new data from its studies of ...presented during the 50th American Society of Hema...
Breaking Medicine Technology:Micromet Expands Committed Equity Financing Facility to $75 Million 2Micromet Expands Committed Equity Financing Facility to $75 Million 3Micromet Expands Committed Equity Financing Facility to $75 Million 4Micromet Expands Committed Equity Financing Facility to $75 Million 5Micromet Expands Committed Equity Financing Facility to $75 Million 6Reprogrammable Cell Type Depends on a Single Gene to Keep Its Identity 2Reprogrammable Cell Type Depends on a Single Gene to Keep Its Identity 3Sunesis Announces New Data on Voreloxin for Acute Myeloid Leukemia To Be Presented at ASH 2Sunesis Announces New Data on Voreloxin for Acute Myeloid Leukemia To Be Presented at ASH 3Stern + Associates Signs New Clients to Health Care Practice 26591 1Stern + Associates Signs New Clients to Health Care Practice 26591 2Hurricane Devastation Touches the Nations Blood Supply 26589 1Hurricane Devastation Touches the Nations Blood Supply 26589 2AdvaMed 2008 Sponsor Participation Increases by 52 25 26587 1AdvaMed 2008 Sponsor Participation Increases by 52 25 26587 2AdvaMed 2008 Sponsor Participation Increases by 52 25 26587 3AdvaMed 2008 Sponsor Participation Increases by 52 25 26587 4alli 28TM 29 Partners with Breast Cancer Network of Strength 28TM 29 to Support Women Challenged by Breast Cancer Weight Loss or Both 7814 1alli 28TM 29 Partners with Breast Cancer Network of Strength 28TM 29 to Support Women Challenged by Breast Cancer Weight Loss or Both 7814 2alli 28TM 29 Partners with Breast Cancer Network of Strength 28TM 29 to Support Women Challenged by Breast Cancer Weight Loss or Both 7814 3
...NEVA, Switzerland, May 2, 2007 – Merck,Seron...I data on,safinamide, a new agent in Phase III dev...sease symptoms, were presented by Professor,Fabriz...th Annual,Meeting in Boston, Massachusetts, USA. T...d, double blind, placebo-controlled,international...
...ublished today in the Journal of the National Canc...and, 2 May 2007 - In a study published today in,th...novative cancer,drug MabThera was shown to improve...less of the chemotherapy regimen used.1 The,review...as seen for,the first time in patients with mantle...
Other Medicine Technology:Phase III Data on Safinamide in Parkinson’s Disease Presented,at American Academy of Neurology 59th Annual Meeting 2Phase III Data on Safinamide in Parkinson’s Disease Presented,at American Academy of Neurology 59th Annual Meeting 3Phase III Data on Safinamide in Parkinson’s Disease Presented,at American Academy of Neurology 59th Annual Meeting 4Phase III Data on Safinamide in Parkinson’s Disease Presented,at American Academy of Neurology 59th Annual Meeting 5MabThera Significantly Increases Survival of Lymphoma Patients,Regardless of Chemotherapy Regimen 2MabThera Significantly Increases Survival of Lymphoma Patients,Regardless of Chemotherapy Regimen 3MabThera Significantly Increases Survival of Lymphoma Patients,Regardless of Chemotherapy Regimen 4